Latest Cortisol Stories

Hormonal issues including premenstrual symptoms, infertility, menopause, erectile dysfunction, and prostate cancer are becoming common among Americans. Dr. J G Moellendorf along with nearly two hundred health care professionals recently gathered in Milwaukee, Wisconsin to discuss the most current research in solving hormonal challenges using natural, drug-free methods. Sturgeon Bay, WI (PRWEB) December 18, 2012 Sturgeon Bay, Wisconsin Chiropractor, Dr. J G Moellendorf, DC, ND, LCP joined...

Bullying among children may be a threat to their future mental health A recent study by a researcher at the Centre for Studies on Human Stress (CSHS) at the Hôpital Louis-H. Lafontaine and professor at the Université de Montréal suggests that bullying by peers changes the structure surrounding a gene involved in regulating mood, making victims more vulnerable to mental health problems as they age. The study published in the journal Psychological Medicine seeks to better understand...

SAN FRANCISCO, Dec. 17, 2012 /PRNewswire/ -- Music has been incorporated into medical practice since before the ancient Greeks. However, though practitioners have been convinced of music's health benefits for thousands of years, there had been little peer-reviewed research to back them up. But recent studies are providing an empirical backbone for the anecdotal evidence. A 2012 scientific review, published in the journal Nutrition, collects information from a number of studies to...

EAST HANOVER, N.J., Dec. 15, 2012 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor(®) (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative(3). Signifor is the first medicine to be approved in the US that addresses the underlying mechanism of Cushing's disease, a serious, debilitating endocrine disorder caused by the...

EAST HANOVER, N.J., Dec. 14, 2012 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor(®) (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative(3). Signifor is the first medicine to be approved in the US that addresses the underlying mechanism of Cushing's disease, a serious, debilitating endocrine disorder caused by the...

redOrbit Staff & Wire Reports - Your Universe Online A group of scientists from the University of Granada’s Group of Neuropsychology and Clinical Psychoneuroimmunology has discovered a connection between levels of the hormone cortisol in a person’s saliva and their ability to make good decisions in high-stress situations, highlighting yet another link between mind and body. The researchers study, titled “Can decision-making skills affect responses to psychological stress in...

[ Watch the Video: Light Exposure Leads To Depression, Learning Issues ] Connie K. Ho for redOrbit.com – Your Universe Online Night owls beware: scientists from Johns Hopkins University recently revealed that when people routinely work late at night, they have an increased risk of developing depression and learning issues. This change is not only due to lack of sleep, but also a result of the exposure to bright light at night from items like computers, laptops and iPads. The team...

Connie K. Ho for redOrbit.com – Your Universe Online Researchers from the University of Wisconsin-Madison recently discovered that early family stress during infancy could be related to changes that occur in the daily brain function and anxiety of teenage girls. The data was pooled from a population study that looked at the relationship between stress and the developmental pathway of the brain. For female infants who lived in homes with stressed out mothers, they were more likely to...

EAST HANOVER, N.J., Nov. 7, 2012 /PRNewswire/ -- The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor(®) (pasireotide) for the treatment of patients with Cushing's disease who require medical therapeutic intervention. "We are encouraged by today's favorable advisory committee recommendation for pasireotide in Cushing's disease and will work closely with the FDA as it...

redOrbit Staff & Wire Reports - Your Universe Online While the general public has long believed that stress can cause medical issues, researchers at Penn State University say it is the way people react to potential stress-inducing stimuli, and not the stressors themselves, that determine whether those individuals will fall ill or suffer other adverse health effects. The Penn State researchers, led by professor of human development and family studies David Almeida, analyzed a group...